Pfizer CEO Ian Read’s pay packet cut from $27.9m to $19.5m

pharmafile | March 15, 2019 | News story | Medical Communications CEO, Ian Read, Pfizer, compensation, pay packet, salary 

Ian Read has seen his total compensation cut from a sum of $27.9 million in 2018 to $19.5 million this year.

Pfizer previously boosted CEO Ian Read’s total pay packet from a sum of $17.3 million in 2016 to a total of $27.9 million the following year, as part of an effort to ensure the Scottish-born pharma chief stayed on the job, according to Bloomberg.

The 61% pay rise came as Pfizer sought to offer the now 66 year old CEO a “compelling incentive” to stay with the US firm. As part of the deal, Read was obliged to stay with Pfizer through to March 2019 while agreeing not to work with competitors for a minimum of two years.

 The pay cut comes as Read named veteran insider Albert Bourla as his successor. Greek vetinarian Bourla, 56, has worked for Pfizer for 25 years.

The reduced pay packet places Read in third place among pharma CEOs after AbbVie’s Richard Gonzalez ($21.3 million) and J&J’s Alex Gorsky ($20 million).

Louis Goss

Related Content


FDA committee votes in favour of Pfizer’s RSV vaccine for maternal immunisation

Pfizer has announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) from the …

Thermo Fisher and Pfizer collaborate on NGS-based cancer tests

Scientific equipment provider Thermo Fisher and US pharmaceutical firm Pfizer have announced a collaboration to …


FDA approves Pfizer’s pneumococcal conjugate vaccine for infants and children

Pfizer has announced that the US Food and Drug Administration (FDA) has approved its PREVNAR …

Latest content